NO and cardiac diastolic function

Cardiovascular Research

Volumn 43, Issue 3, 1999, Pages 595-606

  Paulus, Walter J ^a   Shah, Ajay M ^b  

^a CARDIOVASCULAR CENTER   (Belgium)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Clinical; Diastole; Endothelial function; Experimental; General physiology; Heart; Heart failure; Nitric oxide; Pathophysiology; Ventricular function

Indexed keywords

BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE DONOR; SUBSTANCE P;

CELL FUNCTION; DIASTOLE; ENZYME INHIBITION; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HEART TRANSPLANTATION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0033566889     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00151-0     Document Type: Review

References (92)

1. Smith J.A., Shah A.M., Lewis M.J. Factors released from endothelium of the ferret and pig modulate myocardial contraction. J Physiol. 439:1991;1-14.
2. Lewis M.J., Shah A.M. Endothelial modulation of cardiac function. 1997;Harwood Academic Publishers, Amsterdam.
3. Kelly R.A., Balligand J.L., Smith T.W. Nitric oxide and cardiac function. Circ Res. 79:1996;363-380.
4. Shah A.M. Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res. 31:1996;847-867.
5. Mohan P., Brutsaert D.L., Paulus W.J., Sys S.U. Myocardial contractile response to nitric oxide and cGMP. Circulation. 93:1996;1223-1229.
6. Kojda G., Kottenberg K., Nix P., et al. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular muscle. Circ Res. 78:1996;91-101.
7. ++ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase ativation. J Biol Chem. 268:1993;26286-26295.
8. Finkel M.S., Oddis C.V., Mayer O.H., Hattler B.G., Simmons R.L. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther. 272:1995;945-952.
9. Recchia F.A., McConnell P.I., Bernstein R.D., et al. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res. 83:1998;969-979.
10. f. Circ Res. 81:1997;60-68.
11. Szabolcs M., Michler R.E., Yang X., et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation. 94:1996;1665-1673.
12. Kim Y-M Bombeck C.A., Billiar T.R. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res. 84:1999;253-256.
13. Calderone A., Thaik C.M., Takahashi N., Chang D.L.F., Colucci W.S. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest. 101:1998;812-818.
14. Campbell D.L., Stamler J.S., Strauss H.C. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol. 108:1996;277-293.
15. Stoyanovsky D., Murphy T., Anno P.R., Kim Y.-M., Salama G. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium. 21:1997;19-29.
16. Meszaros L.G., Minarovic I., Zahradnikova A. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett. 380:1996;49-52.
17. Meulemans A.L., Sipido K.R., Sys S.U., Brutsaert D.L. Atriopeptin III induces early relaxation of isolated mammalian papillary muscle. Circ Res. 62:1988;1171-1174.
18. Shah A.M., Meulemans A.L., Brutsaert D.L. Myocardial inotropic responses to aggregating platelets and modulation by the endocardium. Circulation. 79:1989;1315-1323.
19. Shah A.M., Andries L.J., Meulemans A.L., Brutsaert D.L. Endocardium modulates myocardial inotropic response to 5-hydroxytryptamine. Am J Physiol. 257:1989;H1790-H1797.
20. Mohan P., Brutsaert D.L., Sys S.U. Myocardial performance is modulated by interaction of cardiac endothelium-derived nitric oxide and prostaglandins. Cardiovasc Res. 29:1995;637-640.
21. Flesch M., Kilter H., Cremers B., et al. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmacol Exp Ther. 281:1997;1340-1349.
22. 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest. 102:1998;1377-1384.
23. Grocott-Mason R., Fort S., Lewis M.J., Shah A.M. Myocardial relaxant effect of exogenous nitric oxide in the isolated ejecting heart. Am J Physiol. 266:1994;H1699-H1705.
24. Grocott-Mason R., Anning P., Evans H., Lewis M.J., Shah A.M. Modulation of left ventricular relaxation in the isolated ejecting heart by endogenous nitric oxide. Am J Physiol. 267:1994;H1804-H1813.
25. Anning P.B., Grocott-Mason R., Lewis M.J., Shah A.M. Enhancement of left ventricular relaxation in the isolated rat heart by an angiotensin-converting enzyme inhibitor. Circulation. 92:1995;2660-2665.
26. Kichuk M.R., Seyedi N., Zhang X.P., et al. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation. 94:1996;44-51.
27. 2+ in intact cardiac myocytes. Circ Res. 74:1994;970-978.
28. Ito N., Bartunek J., Spitzer K.W., Lorell B.H. Effects of the nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes. Circulation. 95:1997;2303-2311.
29. Vila-Petrof M.G., Lakatta E.G., Sollott S.J. Nitric oxide: a multifaceted modulator of cardiac contractility. Asia Pacific Heart J. 7:1998;38-42.
30. Pfitzer G., Ruegg J.C., Flockerzi V., Hoffman F. cGMP-dependent protein kinase decreases calcium sensitivity of skinned cardiac fibers. FEBS Lett. 149:1982;171-175.
31. Lew W.Y.W., Ryan J., Yasuda S. Lipopolysaccharide induces cell shrinkage in rabbit ventricular cardiac myocytes. Am J Physiol. 272:1997;H2989-H2993.
32. 2+ responsiveness in aequorin-loaded ferret myocardium. Circ Res. 69:1991;582-589.
33. 2+ and pH in isolated beating rabbit hearts and myocytes loaded with the indicator indo-1. J Physiol. 480:1994;203-215.
34. Lakatta E.G. Length modulation of muscle performance: Frank-Starling law of the heart. Fozzard H.A., Haber E., Jennings R.B., Katz A.M., Morgan H.E. The heart and cardiovascular system. 1992;1325-1351 Raven Press, New York.
35. Cingolani H.E., Alvarez B.V., Ennis I.L., Camilion de Hurtado M.C. Stretch-induced alkalinization of feline papillary muscle: an autocrine-paracrine system. Circ Res. 33:1998;775-780.
36. Prendergast B.D., Sagach V.F., Shah A.M. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation. 96:1997;1320-1329.
37. Sagach V.F., Shimanskaya T.V., Sagach V.V., Bogomolets A.A. Coronary endothelium dysfunction and heart failure. J Heart Failure. 5:1998;79. Abstract.
38. Pinsky D.J., Patton S., Mesaros S., et al. Mechanical transduction of nitric oxide synthesis in the beating heart. Circ Res. 81:1997;372-379.
39. Paulus W.J., Vantrimpont P.J., Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation. 89:1994;2070-2078.
40. Brodie B.R., Grossman W., Mann T., McLaurin L.P. Effects of sodium nitroprusside on left ventricular diastolic pressure-volume relations. J Clin Invest. 59:1977;59-68.
41. Carroll J.D., Lang R.M., Neumann A.L., Borow K.M., Rajfer S.I. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. Circulation. 74:1986;815-825.
42. Kingma L., Smiseth O.A., Belenkie I., et al. A mechanism for the nitroglycerin-induced downward shift of the left ventricular diastolic pressure-diameter relationship of patients. Am J Cardiol. 57:1986;673-677.
43. Krogmann O.N., Rammos S., Jakob M., Corin W.J., Hess O.M., et al. Left ventricular diastolic function late after coarctation repair in childhood: influence of left ventricular hypertrophy. J Am Coll Cardiol. 21:1993;1454-1461.
44. Paulus W.J., Vantrimpont P.J., Shah A.M. Paracrine coronary endothelial control of left ventricular function in humans. Circulation. 92:1995;2119-2126.
45. Rubanyi G.M., Romero J.C., Vanhoutte P.M. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 250:1986;H1145-H1149.
46. Hutcheson I.R., Griffith T.M. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. Am J Physiol. 261:1991;H257-H262.
47. Lamontagne D., Pohl U., Busse R. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res. 70:1992;123-130.
48. Feron O., Belhassen L., Kobzik L., et al. Endothelial nitric oxide synthase targeting to caveolae. J Biol Chem. 271:1996;22810-22814.
49. Wollenberger A., Babskii E.B., Krause E.G., et al. Cyclic changes in levels of cyclic AMP and cyclic GMP in frog myocardium during the cardiac cycle. Biochem Biophys Res Commun. 55:1973;446-452.
50. How to diagnose diastolic heart failure. European Heart J. 19:1998;990-1003.
51. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci. USA. 87:1990;1620-1624.
52. Shah A.M., Silverman H.S., Griffiths E.J., Spurgeon H.A., Lakatta E.G. cGMP prevents delayed relaxation at reoxygenation after brief hypoxia in isolated cardiac myocytes. Am J Physiol. 268:1995;H2396-H2404.
53. Draper N.J., Shah A.M. Beneficial effects of a nitric oxide donor on recovery of contractile function following brief hypoxia in isolated rat heart. J Mol Cell Cardiol. 29:1997;1195-1205.
54. Schluter K.D., Weber M., Schraven E., Piper H.M. NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action. Am J Physiol. 267:1994;H1461-H1466.
55. Wang P.H., Zweier J.L. Measurement of nitric oxide and peroxynitrite generation in the post-ischaemic heart-evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem. 271:1996;29223-29230.
56. Xie Y.-W., Kaminski P.M., Wolin M.S. Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res. 82:1998;891-897.
57. El-Omar M.M., Lord R., Shah A.M. Role of iNOS in post-hypoxic contractile dysfunction of diabetic cardiomyopathy. Circulation. 98:1998;I-112. Abstract.
58. MacCarthy P.A., Shah A.M. Endothelial dysfunction blunts LV relaxant effect of captopril in pressure-overload hypertrophy. J Mol Cell Cardiol. 30:1998;A178. Abstract.
59. Bauersachs J., Bouloumie A., Mulsch A., et al. Vasodilator function in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide production. Cardiovasc Res. 37:1998;772-779.
60. Bayraktutan U., Yang Z.-K., Shah A.M. Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat. Cardiovasc Res. 38:1998;719-726.
61. Matter CM, Mandinov L, Kaufmann PA et al. Effects of NO-donors on LV diastolic function in patients with severe pressure-overload hypertrophy. Circulation 1999;in press.
62. Cannon P.J., Yang X., Szabolcs M.J., et al. The role of inducible nitric oxide synthase in cardiac allograft rejection. Cardiovasc Res. 38:1998;6-15.
63. Lewis N.P., Tsao P.S., Rickenbacher P.R., et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation. 93:1996;720-729.
64. Paulus W.J. Nitric oxide and cardiac contraction: clinical studies. Lewis M.J., Shah A.M. Endothelial modulation of cardiac function. 1997;35-51 Harwood Academic Publishers, Amsterdam.
65. Bartunek J., Shah A.M., Vanderheyden M., Paulus W.J. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation. Circulation. 95:1997;90-96.
66. Paulus W.J., Kästner S., Pujadas P., et al. Left ventricular contractile effects of inducible nitric oxide synthase in the human allograft. Circulation. 96:1997;3436-3442.
67. Hare J.M., Loh E., Creager M.A., Colucci W.S. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
68. De Belder A.J., Radomski M.W., Why H.J.F., et al. Nitric oxide synthase in human myocardium. Lancet. 341:1993;84-85.
69. Haywood G.A., Tsao P.S., von der Leyen H.E., et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094.
70. Habib F.M., Springall D.R., Daies G.J., et al. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 347:1996;1151-1155.
71. Drexler H., Kästner S., Strobel A., et al. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol. 32:1998;955-963.
72. Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor α and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711.
73. Satoh M., Nakamura M., Tamura G., et al. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol. 29:1997;716-724.
74. Vejlstrup N.G., Bouloumie A., Boesgaard S., et al. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. J Mol Cell Cardiol. 30:1998;1215-1223.
75. Fukuchi M., Hussain S.N.A., Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure. Their relation to lesion site and β-adrenergic receptor therapy. Circulation. 98:1998;132-139.
76. Stein B., Eschenhagen T., Rüdiger J., et al. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. J Am Coll Cardiol. 32:1998;1179-1186.
77. Luss H., Li R.-K., Shapiro R.A., et al. Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNγ, and LPS. J Mol Cell Cardiol. 29:1997;1153-1165.
78. Khadour F.H., Kao R.H., Park S., et al. Age-dependent augmentation of cardiac endothelial NOS in a genetic rat model of heart failure. Am J Physiol. 273:1997;H1223-H1230.
79. Harding S.E., Davies C.H., Money-Kyrle A.M., Poole-Wilson P.A. An inhibitor of nitric oxide synthase does not increase contraction or β-adrenoceptor sensitivity of ventricular myocytes from failing human heart. Cardiovasc Res. 40:1998;523-529.
80. Treasure C.B., Vita J.A., Cox D.A., et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81:1990;772-779.
81. Smith C.J., Sun D., Hoegler C., et al. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res. 78:1996;58-64.
82. Mohri M., Egashira K., Tagawa T., et al. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. Hypertension. 30:1997;50-56.
83. Wang J., Yi G.-H., Knecht M., et al. Physical training alters the pathogenesis of pacing-induced heart failure through endothelium-mediated mechanisms in awake dogs. Circulation. 96:1997;2683-2692.
84. Wever R.M.F., Luscher T.F., Cosentino F., Rabelink T.J. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 97:1998;108-112.
85. Cosentino F., Patton S., d'Uscio L.V., et al. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest. 101:1988;1530-1537.
86. Heymes C., Vanderheyden M., Paulus W.J. Myocardial iNOS gene expression modulates left ventricular contractile response to β-adrenergic stimulation in dilated cardiomyopathy. Circulation. 98:1998;I-361. Abstract.
87. Heymes C, Vanderheyden M, Bronzwaer JGF, Shah AM, Paulus WJ. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 1999;in press.
88. Vanderheyden M., Pujadas P., Paulus W.J. Paracrine myocardial contractile response to coronary endothelial stimulation in dilated cardiomyopathy. Circulation. 96:1997;I-392. Abstract.
89. Matsuoka H., Nakata M., Kohno K., et al. Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension. 27:1996;14-18.
90. McDonald K.M., Francis G.S., Matthews J., Hunter D.W., Cohn J.N. Chronic oral nitrate therapy prevents long-term ventricular remodelling in the dog. J Am Coll Cardiol. 21:1993;514-522.
91. Matsubara B.B., Matsubara L.S., Zornoff A.M., Franco M., Janicki J.S. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats. Basic Res Cardiol. 93:1998;173-181.
92. Wang J., Wolin M.S., Hintze T.H. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res. 73:1993;829-838.